Islet Holdings, Inc.
OTC: ISHI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- J. Michael Heil
- Employees
- 7
- Headquarters
- Grass Valley, United States
- IPO year
- 2012
- Market cap
- $5.0
- Website
- https://www.revitacell.com
Loading ISHI…
Loading profile data…Frequently asked questions about ISHI
What does Islet Holdings, Inc. (ISHI) do?
Islet Holdings, Inc. is a U.S.-based company dedicated to the skincare market, offering a comprehensive array of products. Their extensive catalog includes specialized solutions for various concerns such as acne-prone skin, anti-aging, berridroxies, botanical formulations, eye treatments, moisturizers, creams, sensitive skin, toners, cleansers,...
Where does ISHI trade?
Islet Holdings, Inc. (ISHI) trades on the Other OTC.
What sector is ISHI in?
Islet Holdings, Inc. (ISHI) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Islet Holdings, Inc.?
J. Michael Heil is the chief executive officer of Islet Holdings, Inc. (ISHI).
Where is Islet Holdings, Inc. headquartered?
Islet Holdings, Inc. is headquartered in United States.
Does ISHI pay a dividend?
Islet Holdings, Inc. (ISHI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ISHI go public?
Islet Holdings, Inc. (ISHI) completed its initial public offering in 2012.